Regulatory elements in SEM1-DLX5-DLX6 (7q21.3) locus contribute to genetic control of coronal nonsyndromic craniosynostosis and bone density-related traits.
Nicoletti P., Zafer S., Matok L., Irron I., Patrick M., Haklai R., Evangelista JE., Marino GB., Ma'ayan A., Sewda A., Holmes G., Britton SR., Lee WJ., Wu M., Ru Y., Arnaud E., Botto L., Brody LC., Byren JC., Caggana M., Carmichael SL., Cilliers D., Conway K., Crawford K., Cuellar A., Di Rocco F., Engel M., Fearon J., Feldkamp ML., Finnell R., Fisher S., Freudlsperger C., Garcia-Fructuoso G., Hagge R., Heuzé Y., Harshbarger RJ., Hobbs C., Howley M., Jenkins MM., Johnson D., Justice CM., Kane A., Kay D., Gosain AK., Langlois P., Legal-Mallet L., Lin AE., Mills JL., Morton JEV., Noons P., Olshan A., Persing J., Phipps JM., Redett R., Reefhuis J., Rizk E., Samson TD., Shaw GM., Sicko R., Smith N., Staffenberg D., Stoler J., Sweeney E., Taub PJ., Timberlake AT., Topczewska J., Wall SA., Wilson AF., Wilson LC., Boyadjiev SA., Wilkie AOM., Richtsmeier JT., Jabs EW., Romitti PA., Karasik D., Birnbaum RY., Peter I.
PURPOSE: The etiopathogenesis of coronal nonsyndromic craniosynostosis (cNCS), a congenital condition defined by premature fusion of 1 or both coronal sutures, remains largely unknown. METHODS: We conducted the largest genome-wide association study of cNCS followed by replication, fine mapping, and functional validation of the most significant region using zebrafish animal model. RESULTS: Genome-wide association study identified 6 independent genome-wide-significant risk alleles, 4 on chromosome 7q21.3 SEM1-DLX5-DLX6 locus, and their combination conferred over 7-fold increased risk of cNCS. The top variants were replicated in an independent cohort and showed pleiotropic effects on brain and facial morphology and bone mineral density. Fine mapping of 7q21.3 identified a craniofacial transcriptional enhancer (eDlx36) within the linkage region of the top variant (rs4727341; odds ratio [95% confidence interval], 0.48[0.39-0.59]; P = 1.2E-12) that was located in SEM1 intron and enriched in 4 rare risk variants. In zebrafish, the activity of the transfected human eDlx36 enhancer was observed in the frontonasal prominence and calvaria during skull development and was reduced when the 4 rare risk variants were introduced into the sequence. CONCLUSION: Our findings support a polygenic nature of cNCS risk and functional role of craniofacial enhancers in cNCS susceptibility with potential broader implications for bone health.